All Industries

Top Biotech Companies

325 Biotech companies, sorted by total funding raised.

IF
Impossible Foods

Food technology company creating plant-based meat and dairy products that replicate the taste and...

Redwood City, United StatesAgtech, Biotech
Series G+·$1.9B·Nov 2021
N
Neuralink

Neuralink is building a brain-computer interface for medical needs and greater human potential.

Fremont, United StatesBiotech, Healthcare
Series E·$1.2B·Jun 2025
AB
Abogen Biosciences

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.

Suzhou, ChinaBiotech, mRNA Therapeutics
Funding undisclosed
C
Curie.Bio

Biotech venture firm and therapeutics accelerator that invests at seed stage and acts as a drug d...

Boston, United StatesBiotech, Drug Discovery
Funding undisclosed
Z
Zymergen

Zymergen was a biomanufacturing company using AI and machine learning to engineer microbes for pr...

Emeryville, United StatesAdvanced Materials, Artificial Intelligence
Funding undisclosed
EJ
Eat Just

Alternative protein company making plant-based eggs and cultivated meat from animal cells

Alameda, United States201–500Biotech, Food Tech
Funding undisclosed
BT
Biosplice Therapeutics
San Diego, United StatesBiotech
Funding undisclosed
K
Kry

European digital healthcare platform connecting patients with licensed doctors via video consulta...

Stockholm, SwedenHealthcare, Biotech
Funding undisclosed
Generate Biomedicines
IPO

AI-powered generative biology platform creating novel protein therapeutics across antibodies, pep...

Cambridge, United States201–500Artificial Intelligence, Biotech
Corporate Round·$693.0M·Dec 2024
I
insitro

High-quality perturbational data generation and AI to discover new targets and enable drug discov...

South San Francisco, United States201–500Artificial Intelligence, Healthcare
Series C·$643.0M·Mar 2021
S
Solugen

Decarbonizing the chemicals industry.

Houston, United States51–200Biotech, Climate Tech
Series D·$612.2M·Oct 2022
UF
UPSIDE Foods

A pioneer in the cell-based meat industry.

Berkeley, United StatesBiotech, Food Tech
Series C·$581.0M·Apr 2022
GH
Guardant Health
IPO

Guardant Health is an oncology company.

Palo Alto, United StatesBiotech, Healthcare
Series E·$540.0M·May 2017
M
Metsera

Clinical-stage biopharmaceutical company developing next-generation oral and injectable medicines...

New York, United StatesBiotech, Obesity
Funding undisclosed
IM
Insilico Medicine

AI-driven drug discovery company using generative AI and deep learning to design novel drug candi...

Hong Kong, Hong KongArtificial Intelligence, Biotech
Funding undisclosed
R
Recursion
IPO

AI-powered drug discovery and development company that uses biological and chemical datasets, mac...

Salt Lake City, United StatesArtificial Intelligence, Biotech
Corporate Round·$482.9M·Jul 2023
CB
Colossal Biosciences

De-extinction and genetic engineering company working to bring back the woolly mammoth and other ...

Dallas, United States51–200Biotech, Genetics
Funding undisclosed
H
Helix

Population genomics and viral surveillance company enabling health systems and public health orga...

San Mateo, United StatesBiotech, Diagnostics
Funding undisclosed
B
Benchling

Unlocking the power of biotech with modern software for modern science

San Francisco, United States501–1000Biotech, SaaS
Series F·$412.0M·Nov 2021
P
PacBio
USABiotech, Genomics
Funding undisclosed
Athelas

Digital tools for healthcare providers

Mountain View, United States51–200Biotech, Healthcare
Growth Equity·$404.0M·Jun 2025
Color

Population-scale health company delivering genetic testing, cancer screening, and virtual clinica...

Burlingame, United StatesLife Sciences, Biotech
Series E·$402.0M·Nov 2021
AB
Adaptive Biotechnologies
IPO

Immune-driven medicine company mapping the human adaptive immune system

Seattle, United States501–1000Biotech, Healthcare
Funding undisclosed
FB
Formation Bio

Tech-native pharma company acquiring and developing clinical-stage assets via proprietary sourcin...

New York, United States51–200Artificial Intelligence, Biotech
Series D·$372.0M·Jun 2024
DT
Denali Therapeutics
IPO

Denali Therapeutics is a biotechnology company focused on discovering and developing treatments f...

South San Francisco, United StatesBiotech
Funding undisclosed